0001209191-20-058031.txt : 20201112 0001209191-20-058031.hdr.sgml : 20201112 20201112170502 ACCESSION NUMBER: 0001209191-20-058031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201109 FILED AS OF DATE: 20201112 DATE AS OF CHANGE: 20201112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Busch Andreas CENTRAL INDEX KEY: 0001775029 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38787 FILM NUMBER: 201307835 MAIL ADDRESS: STREET 1: C/O CYCLERION THERAPEUTICS, INC. STREET 2: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc. CENTRAL INDEX KEY: 0001755237 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831895370 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-09 0 0001755237 Cyclerion Therapeutics, Inc. CYCN 0001775029 Busch Andreas C/O CYCLERION THERAPEUTICS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Innovation Officer Common Stock 2020-11-09 4 P 0 125000 2.53 A 254704 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.48 to $2.60, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. The reporting person acquired 2,204 and 2,500 shares of Common Stock under the issuer's employee stock purchase plan on November 29, 2019 and May 29, 2020, respectively. /s/ David Slatcher, Attorney-in-Fact 2020-11-12